Skip to main content
Top
Published in: Journal of Assisted Reproduction and Genetics 6/2013

01-06-2013 | Gonadal Physiology and Disease

The significance of serum anti-Müllerian hormone (AMH) levels in patients over age 40 in first IVF treatment

Authors: Yoko Tokura, Osamu Yoshino, Sayaka Ogura-Nose, Hiroshi Motoyama, Miyuki Harada, Yutaka Osuga, Yasushi Shimizu, Motohiro Ohara, Takeshi Yorimitsu, Osamu Nishii, Shiro Kozuma, Toshihiro Kawamura

Published in: Journal of Assisted Reproduction and Genetics | Issue 6/2013

Login to get access

Abstract

Purpose

Although studies of serum anti-Müllerian hormone (AMH) in predicting ovarian reserve are numerous, many studies utilized patients under age 40. However, the assessment of ovarian reserve is especially critical in older infertile women. This study evaluates the significance of AMH level in patients over age 40 at the time of their first in vitro fertilization (IVF) treatment.

Methods

Forty-nine women over age 40 were studied. Although serum samples were taken prior to their IVF treatments, the data of serum AMH of patients were not taken into consideration to determine the therapy strategy, including follicle induction in which clomiphene citrate and human menopausal gonadotropin were used.

Result(s)

Twelve out of 49 patients achieved a clinical pregnancy (24.4 %). There was a positive correlation between serum AMH levels and the number of oocytes retrieved (P < 0.0001). The ROC curve analysis for prediction of poor ovarian response, ≤3 retrieved oocytes, showed that the optimum cut-off level was < 1.0 ng/mL for AMH. The lower AMH group (AMH < 1.0 ng/ml) showed less chance of undergoing embryo transfer than the higher AMH group (AMH ≥1.0 ng/ml). There was no difference in pregnancy rate between the two groups. Five out of 12 pregnant women exhibited AMH levels of less than 0.4 ng/ml.

Conclusion(s)

Assessment of serum AMH concentration in older patients is useful for the prediction of oocytes numbers which may be obtained in IVF. A cut-off level of 1.0 ng/ml AMH can be used to predict poor ovarian response. This cut-off level of AMH of 1.0 ng/ml might be useful to predict whether patients could have an embryo transfer, but had no power to predict achieving pregnancy. On the other hand, our data also showed that patients over age 40 with extreme low levels of AMH still had a chance of pregnancy.
Literature
1.
go back to reference Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Updat. 2006;12(6):685–718.CrossRef Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Updat. 2006;12(6):685–718.CrossRef
2.
go back to reference Broer SL, Mol BWJ, Hendriks D, Broekmans FJM. Role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertil Steril. 2009;91(3):705–14.PubMedCrossRef Broer SL, Mol BWJ, Hendriks D, Broekmans FJM. Role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertil Steril. 2009;91(3):705–14.PubMedCrossRef
3.
go back to reference Ferraretti AP et al. ESHRE consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization: the Bologna criteria. Human Reprod (Oxford, England). 2011;26(7):1616–24.CrossRef Ferraretti AP et al. ESHRE consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization: the Bologna criteria. Human Reprod (Oxford, England). 2011;26(7):1616–24.CrossRef
4.
go back to reference Fujimoto A et al. Predictive factors of successful pregnancy after assisted reproductive technology in women aged 40 years and older. Reprod Med Biol. 2009;8(4):145–9.CrossRef Fujimoto A et al. Predictive factors of successful pregnancy after assisted reproductive technology in women aged 40 years and older. Reprod Med Biol. 2009;8(4):145–9.CrossRef
5.
go back to reference Khader A et al. External validation of anti-Müllerian hormone based prediction of live birth in assisted conception. J Ovarian Res. 2013;6(1):3.PubMedCrossRef Khader A et al. External validation of anti-Müllerian hormone based prediction of live birth in assisted conception. J Ovarian Res. 2013;6(1):3.PubMedCrossRef
6.
go back to reference Leridon H. Demographic effects of the introduction of steroid contraception in developed countries. Hum Reprod Updat. 2006;12(5):603–16.CrossRef Leridon H. Demographic effects of the introduction of steroid contraception in developed countries. Hum Reprod Updat. 2006;12(5):603–16.CrossRef
7.
go back to reference Lie Fong S et al. Anti-Müllerian hormone: a marker for oocyte quantity, oocyte quality and embryo quality? Reprod Biomed Online. 2008;16(5):664–70.PubMedCrossRef Lie Fong S et al. Anti-Müllerian hormone: a marker for oocyte quantity, oocyte quality and embryo quality? Reprod Biomed Online. 2008;16(5):664–70.PubMedCrossRef
8.
go back to reference La Marca A et al. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Updat. 2010;16(2):113–30.CrossRef La Marca A et al. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Updat. 2010;16(2):113–30.CrossRef
9.
go back to reference La Marca A, Stabile G, Carducci Artenisio A, Volpe A. Serum anti-Mullerian hormone throughout the human menstrual cycle. Human Reprod (Oxford, England). 2006;21(12):3103–7.CrossRef La Marca A, Stabile G, Carducci Artenisio A, Volpe A. Serum anti-Mullerian hormone throughout the human menstrual cycle. Human Reprod (Oxford, England). 2006;21(12):3103–7.CrossRef
10.
go back to reference Van Rooij IAJ et al. Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve. Human Reprod (Oxford, England). 2002;17(12):3065–71.CrossRef Van Rooij IAJ et al. Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve. Human Reprod (Oxford, England). 2002;17(12):3065–71.CrossRef
11.
go back to reference Spandorfer SD et al. An analysis of the effect of age on implantation rates. J Assist Reprod Genet. 2000;17(6):303–6.PubMedCrossRef Spandorfer SD et al. An analysis of the effect of age on implantation rates. J Assist Reprod Genet. 2000;17(6):303–6.PubMedCrossRef
12.
go back to reference Spira A. The decline of fecundity with age. Maturitas Suppl. 1988;1:15–22.CrossRef Spira A. The decline of fecundity with age. Maturitas Suppl. 1988;1:15–22.CrossRef
13.
go back to reference Weenen C et al. Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod. 2004;10(2):77–83.PubMedCrossRef Weenen C et al. Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod. 2004;10(2):77–83.PubMedCrossRef
14.
go back to reference Weghofer A, Dietrich W, Barad DH, Gleicher N. Live birth chances in women with extremely low-serum anti-Mullerian hormone levels. Human Reprod (Oxford, England). 2011;26(7):1905–9.CrossRef Weghofer A, Dietrich W, Barad DH, Gleicher N. Live birth chances in women with extremely low-serum anti-Mullerian hormone levels. Human Reprod (Oxford, England). 2011;26(7):1905–9.CrossRef
Metadata
Title
The significance of serum anti-Müllerian hormone (AMH) levels in patients over age 40 in first IVF treatment
Authors
Yoko Tokura
Osamu Yoshino
Sayaka Ogura-Nose
Hiroshi Motoyama
Miyuki Harada
Yutaka Osuga
Yasushi Shimizu
Motohiro Ohara
Takeshi Yorimitsu
Osamu Nishii
Shiro Kozuma
Toshihiro Kawamura
Publication date
01-06-2013
Publisher
Springer US
Published in
Journal of Assisted Reproduction and Genetics / Issue 6/2013
Print ISSN: 1058-0468
Electronic ISSN: 1573-7330
DOI
https://doi.org/10.1007/s10815-013-9991-3

Other articles of this Issue 6/2013

Journal of Assisted Reproduction and Genetics 6/2013 Go to the issue